OncoMatch/Clinical Trials/NCT07751159
Radiation Therapy Approaches for People With Prostate Cancer
Is NCT07751159 recruiting? Yes, currently enrolling (Sep 2026). This Phase 2 trial studies non-drug interventions for prostate cancer patients.
The purpose of the study is to explore the best ways of giving radiation therapy to balance cancer control and treatment side effects.
Check if I qualifyExtracted eligibility criteria
Cancer type
Prostate Cancer
Disease stage
Required: Stage NON-METASTATIC
Excluded: Stage IV
Non-metastatic prostate cancer. (Note: cT3a or T3b by MRI or PSMA PET allowed)
Structured fields extracted by AI. May contain errors — verify against the official protocol.
US trial sites
- Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities) · Basking Ridge, New Jersey
- Memorial Sloan Kettering at Monmouth (Limited Protocol Activities) · Middletown, New Jersey
- Memorial Sloan Kettering at Bergen (Limited Protocol Activities) · Montvale, New Jersey
- Memorial Sloan Kettering Suffolk-Commack (Limited Protocol Activities) · Commack, New York
- Memorial Sloan Kettering at Westchester (Limited Protocol Activities) · Harrison, New York
Showing up to 5 US sites.
See all sites on ClinicalTrials.gov →Frequently asked questions
Is NCT07751159 currently recruiting?
Yes, this trial is currently recruiting patients.
What disease stage is eligible?
Stage NON-METASTATIC is required.
Could you qualify for this trial?
Enter your biomarker results to see how this trial's eligibility criteria match your specific cancer profile.
Check if I qualifyRelated pages